Core Laboratories Nv Stock Probability Of Bankruptcy

CLB Stock

USD 15.54 0.02 0.13%

Core Laboratories' odds of distress is under 6% at the present time. It has tiny probability of undergoing some form of financial hardship in the near future. Chance of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Core balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis.

As of March 26, 2025, Market Cap is expected to decline to about 705.7 M. In addition to that, Enterprise Value is expected to decline to about 843.4 M

Core Laboratories NV Company chance of distress Analysis

Core Laboratories' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Core Laboratories Probability Of Bankruptcy

Less than 6%

Most of Core Laboratories' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Core Laboratories probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Core Laboratories odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Core Laboratories NV financial health.

Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.896

Dividend Share

0.04

Earnings Share

0.66

Revenue Per Share

11.17

Quarterly Revenue Growth

0.008

The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Good Will	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Long Term Investments	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.4	0.77	0.51	0.7	0.73	0.88	0.55	0.34	0.41	0.5	0.62	0.47	0.44	0.33	-0.33	-0.44	0.38	0.28	0.35	0.05	0.17	-0.23	0.17	0.1	0.0
Total Stockholder Equity	0.4		-0.13	0.15	0.53	0.3	0.01	0.34	-0.1	0.08	0.17	-0.29	0.19	0.18	0.03	0.25	0.34	0.57	-0.55	0.29	-0.63	0.26	-0.08	-0.05	0.32	-0.12
Net Debt	0.77	-0.13		0.32	0.3	0.49	0.96	0.54	0.4	0.56	0.54	0.91	0.23	0.4	0.41	-0.46	-0.72	0.06	0.74	0.09	0.47	-0.02	-0.44	0.22	-0.21	0.27
Retained Earnings	0.51	0.15	0.32		0.77	0.94	0.5	0.6	-0.16	0.19	0.39	0.51	0.08	0.45	0.42	-0.86	-0.39	-0.21	0.4	-0.18	0.44	-0.6	-0.1	0.28	-0.03	0.14
Accounts Payable	0.7	0.53	0.3	0.77		0.89	0.52	0.66	-0.13	0.09	0.55	0.35	0.25	0.55	0.31	-0.49	-0.24	0.02	0.07	0.06	0.1	-0.24	-0.06	0.04	0.1	0.12
Net Receivables	0.73	0.3	0.49	0.94	0.89		0.67	0.7	-0.05	0.22	0.48	0.59	0.23	0.52	0.41	-0.76	-0.43	-0.08	0.37	-0.02	0.37	-0.4	-0.13	0.23	0.05	0.09
Total Liab	0.88	0.01	0.96	0.5	0.52	0.67		0.63	0.39	0.52	0.63	0.9	0.28	0.52	0.46	-0.55	-0.74	0.08	0.67	0.1	0.42	-0.09	-0.37	0.21	-0.18	0.28
Total Current Assets	0.55	0.34	0.54	0.6	0.66	0.7	0.63		-0.13	0.43	0.8	0.56	0.03	0.69	0.49	-0.65	-0.56	-0.13	0.43	-0.17	0.35	-0.49	-0.38	0.18	-0.27	0.5
Short Term Debt	0.34	-0.1	0.4	-0.16	-0.13	-0.05	0.39	-0.13		0.12	-0.01	0.3	0.36	-0.01	0.03	0.07	-0.31	0.37	0.14	0.43	-0.05	0.46	0.02	-0.15	0.05	-0.07
Intangible Assets	0.41	0.08	0.56	0.19	0.09	0.22	0.52	0.43	0.12		0.46	0.54	-0.27	0.54	0.81	-0.25	-0.43	0.23	0.57	-0.28	0.11	-0.23	-0.82	0.62	-0.1	0.47
Common Stock	0.5	0.17	0.54	0.39	0.55	0.48	0.63	0.8	-0.01	0.46		0.54	-0.07	0.76	0.5	-0.47	-0.64	-0.04	0.4	-0.27	0.22	-0.45	-0.37	-0.02	-0.59	0.8
Long Term Debt	0.62	-0.29	0.91	0.51	0.35	0.59	0.9	0.56	0.3	0.54	0.54		0.0	0.53	0.59	-0.7	-0.83	-0.24	0.91	-0.19	0.7	-0.35	-0.46	0.3	-0.24	0.39
Property Plant Equipment	0.47	0.19	0.23	0.08	0.25	0.23	0.28	0.03	0.36	-0.27	-0.07	0.0		-0.25	-0.43	-0.01	-0.07	0.31	-0.21	0.9	-0.04	0.53	0.62	-0.38	0.35	-0.45
Current Deferred Revenue	0.44	0.18	0.4	0.45	0.55	0.52	0.52	0.69	-0.01	0.54	0.76	0.53	-0.25		0.83	-0.46	-0.67	-0.17	0.43	-0.42	0.22	-0.51	-0.49	0.44	-0.18	0.55
Good Will	0.33	0.03	0.41	0.42	0.31	0.41	0.46	0.49	0.03	0.81	0.5	0.59	-0.43	0.83		-0.46	-0.59	-0.12	0.62	-0.5	0.28	-0.52	-0.74	0.68	-0.02	0.51
Treasury Stock	-0.33	0.25	-0.46	-0.86	-0.49	-0.76	-0.55	-0.65	0.07	-0.25	-0.47	-0.7	-0.01	-0.46	-0.46		0.65	0.47	-0.71	0.29	-0.77	0.75	0.14	-0.25	0.27	-0.36
Net Tangible Assets	-0.44	0.34	-0.72	-0.39	-0.24	-0.43	-0.74	-0.56	-0.31	-0.43	-0.64	-0.83	-0.07	-0.67	-0.59	0.65		0.32	-0.78	0.17	-0.64	0.42	0.21	-0.21	0.33	-0.51
Deferred Long Term Liab	0.38	0.57	0.06	-0.21	0.02	-0.08	0.08	-0.13	0.37	0.23	-0.04	-0.24	0.31	-0.17	-0.12	0.47	0.32		-0.44	0.48	-0.76	0.65	-0.09	-0.03	0.19	-0.21
Long Term Debt Total	0.28	-0.55	0.74	0.4	0.07	0.37	0.67	0.43	0.14	0.57	0.4	0.91	-0.21	0.43	0.62	-0.71	-0.78	-0.44		-0.39	0.83	-0.52	-0.51	0.41	-0.28	0.45
Capital Surpluse	0.35	0.29	0.09	-0.18	0.06	-0.02	0.1	-0.17	0.43	-0.28	-0.27	-0.19	0.9	-0.42	-0.5	0.29	0.17	0.48	-0.39		-0.3	0.77	0.53	-0.4	0.48	-0.55
Short Long Term Debt	0.05	-0.63	0.47	0.44	0.1	0.37	0.42	0.35	-0.05	0.11	0.22	0.7	-0.04	0.22	0.28	-0.77	-0.64	-0.76	0.83	-0.3		-0.6	-0.07	0.11	-0.23	0.28
Long Term Investments	0.17	0.26	-0.02	-0.6	-0.24	-0.4	-0.09	-0.49	0.46	-0.23	-0.45	-0.35	0.53	-0.51	-0.52	0.75	0.42	0.65	-0.52	0.77	-0.6		0.27	-0.26	0.47	-0.62
Cash And Equivalents	-0.23	-0.08	-0.44	-0.1	-0.06	-0.13	-0.37	-0.38	0.02	-0.82	-0.37	-0.46	0.62	-0.49	-0.74	0.14	0.21	-0.09	-0.51	0.53	-0.07	0.27		-0.64	0.18	-0.44
Net Invested Capital	0.17	-0.05	0.22	0.28	0.04	0.23	0.21	0.18	-0.15	0.62	-0.02	0.3	-0.38	0.44	0.68	-0.25	-0.21	-0.03	0.41	-0.4	0.11	-0.26	-0.64		0.22	-0.09
Net Working Capital	0.1	0.32	-0.21	-0.03	0.1	0.05	-0.18	-0.27	0.05	-0.1	-0.59	-0.24	0.35	-0.18	-0.02	0.27	0.33	0.19	-0.28	0.48	-0.23	0.47	0.18	0.22		-0.72
Capital Stock	0.0	-0.12	0.27	0.14	0.12	0.09	0.28	0.5	-0.07	0.47	0.8	0.39	-0.45	0.55	0.51	-0.36	-0.51	-0.21	0.45	-0.55	0.28	-0.62	-0.44	-0.09	-0.72

	2020	2021	2022	2023	2024	2025 (projected)
Return On Assets	(0.17)	0.034	0.0336	0.0625	0.0532	0.096
Gross Profit Margin	0.26	0.22	0.19	0.18	0.16	0.17
Net Debt	313.2M	232.6M	207.0M	200.3M	161.0M	186.6M
Total Current Liabilities	89.8M	90.8M	103.1M	88.1M	97.6M	100.8M
Non Current Liabilities Total	403.3M	329.1M	286.3M	268.5M	235.1M	267.0M
Total Assets	568.6M	580.9M	578.4M	586.4M	590.4M	553.5M
Total Current Assets	165.8M	189.1M	211.7M	223.1M	1.7M	1.6M
Total Cash From Operating Activities	57.9M	36.6M	25.0M	24.8M	56.4M	110.0M

	Return On Equity	0.13
	Return On Asset	0.0553
	Profit Margin	0.06 %
	Operating Margin	0.08 %
	Current Valuation	888.68 M
	Shares Outstanding	46.83 M
	Shares Owned By Insiders	0.95 %
	Shares Owned By Institutions	99.05 %
	Number Of Shares Shorted	6.53 M
	Price To Earning	101.74 X
	Price To Book	2.89 X
	Price To Sales	1.39 X
	Revenue	523.85 M
	Gross Profit	103.33 M
	EBITDA	73.51 M
	Net Income	32.15 M
	Cash And Equivalents	15.43 M
	Cash Per Share	0.29 X
	Total Debt	180.14 M
	Debt To Equity	1.29 %
	Current Ratio	2.23 X
	Book Value Per Share	5.38 X
	Cash Flow From Operations	56.39 M
	Short Ratio	16.64 X
	Earnings Per Share	0.66 X
	Price To Earnings To Growth	1.67 X
	Target Price	18.5
	Number Of Employees	3.5 K
	Beta	2.39
	Market Capitalization	727.69 M
	Total Asset	590.41 M
	Retained Earnings	150.28 M
	Working Capital	129.02 M
	Current Asset	238.55 M
	Current Liabilities	120.76 M
	Annual Yield	0 %
	Five Year Return	2.66 %
	Net Asset	590.41 M
	Last Dividend Paid	0.04

Core Laboratories Nv Stock Probability Of Bankruptcy

Core Laboratories NV Company chance of distress Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Core Laboratories Probability Of Bankruptcy

Core Probability Of Bankruptcy Driver Correlations

Core Probability Of Bankruptcy Peer Comparison

Core Laboratories Main Bankruptcy Drivers

Core Laboratories ESG Sustainability

Core Fundamentals

About Core Laboratories Fundamental Analysis

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY